Embed this press release by copying the code below:
Santarus, Inc. (NASDAQ:SNTS) Investor Alert: Investigation of Takeover at $32 by Salix Pharmaceuticals
Santarus, Inc. (NASDAQ:SNTS) Investor Alert: Investigation of Takeover at $32 by Salix Pharmaceuticals